A pathway-informed mutual exclusivity framework to detect genetic interactions in pediatric cancer. [PDF]
Spinou A +3 more
europepmc +1 more source
FOXA1 Alterations in Prostate Cancer: Expression, Mutation Classes, and Copy Number Changes. [PDF]
Lehrer S, Rheinstein P.
europepmc +1 more source
Estimating the Value of Adding 30 Days to the 180-Day Market Exclusivity of the First-to-File Generic Drug Manufacturer. [PDF]
Sertkaya A +5 more
europepmc +1 more source
SeOMLR: one-step multi-view latent representation with self-weighted ensemble learning for multi-omics cancer subtyping. [PDF]
Song W, Sun Y, Ou-Yang L.
europepmc +1 more source
The multiple generator hypothesis of consciousness. [PDF]
Kirkeby-Hinrup A, Fink SB, Overgaard MS.
europepmc +1 more source
Causal exclusion without explanatory exclusion
The causal/explanatory exclusion argument is one of the principal weapons against the possibility of mental causes/explanations having genuine causal/explanatory have genuine casual/explanatory power. I argue that the causal and the explanatory versions of the exclusion argument should be distinguished.
openaire +1 more source
MAP3K1/MAP2K4 mutations drive breast cancer progression by compensating for TP53 loss through inactivation of the JNK2-p53-FOSL1 axis. [PDF]
Hu S +6 more
europepmc +1 more source
Comprehensive profiling of somatic alterations and HRD characteristics in Chinese germline BRCA-mutated breast cancer patients. [PDF]
Cui H, Zhu M, Ling B, Zhang L.
europepmc +1 more source
The role of support on breastfeeding exclusivity and duration among African migrant mothers in the United States. [PDF]
Addy T +5 more
europepmc +1 more source
US Food and Drug Administration Competitive Generic Therapy Approvals and Drug Competition.
Kho K, Patel R, Chahal HS.
europepmc +1 more source

